Company Analysis

Cronos Group Inc. (CRON)

Nasdaq: CRON · Medicinal Chemicals & Botanical Products · Stayner, ON · filing with the SEC since 2015
Grade6.4
◀ Past 6.1● Present 6.8▶ Future 6.3

Who runs Cronos Group Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Gorenstein Michael Ryan
Chairman, Chief Executive Officer, and President. First filing Dec 2019, latest Mar 17, 2026, 4 filings in all.
Officers reporting now
9
of 13 people with a filing in the last fifteen months
Directors reporting now
4
35 people on the record since 2019
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Wagner AdamSee remarksApr 2024Nov 12, 2026none
Martens ChristopherGeneral ManagerOct 2026Oct 20, 2026none
Buggy ShannonSenior Vice President, Global Head of PeopleNov 2020May 14, 2026none
Kenost Jared MatthewVice President, ControllerFeb 2026May 14, 2026none
Doucet Terrence Gregory JosephGeneral Counsel and Corporate SecretaryApr 2022May 14, 2026none
Weigensberg AryeSenior Vice President, Head of Research and DevelopmentAug 2022May 12, 2026none
Shlimak AnnaChief Financial OfficerMar 2020Mar 20, 2026none
Gorenstein Michael RyanChairman, Chief Executive Officer, and PresidentDec 2019Mar 17, 2026none
Jacobson Jeffrey DavidChief Growth OfficerDec 2019Mar 17, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Adler Jason MarcdirectorDec 2019Aug 7, 2026none
Garnick Murray RdirectorDec 2019Aug 7, 2026none
Rudyk James DanieldirectorDec 2019Aug 7, 2026none
Broughton Darren ChesterdirectorJun 2026Jun 30, 2026none
Earlier names on the record26, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CRON · research, not advice